We are live on ! Find out more
AWP

Accretive Wealth Partners Portfolio holdings

AUM $412M
1-Year Est. Return 15.82%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+15.82%
3 Year Est. Return
+57.32%
5 Year Est. Return
+67.02%
10 Year Est. Return
AUM
$328M
AUM Growth
+$22.8M
Cap. Flow
+$7.2M
Cap. Flow %
2.2%
Top 10 Hldgs %
36.59%
Holding
156
New
6
Increased
90
Reduced
13
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 11.85%
2 Financials 8.2%
3 Consumer Discretionary 5.41%
4 Industrials 4.98%
5 Communication Services 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPGI icon
76
S&P Global
SPGI
$121B
$1.24M 0.38%
2,556
+59
+2% +$31.6K
ODFL icon
77
Old Dominion Freight Line
ODFL
$44.1B
$1.22M 0.37%
8,693
+497
+6% +$76.1K
EFX icon
78
Equifax
EFX
$20.3B
$1.21M 0.37%
4,700
+136
+3% +$34.2K
VRSK icon
79
Verisk Analytics
VRSK
$25.4B
$1.18M 0.36%
4,687
+139
+3% +$38.2K
VOO icon
80
Vanguard S&P 500 ETF
VOO
$979B
$1.17M 0.36%
1,905
+77
+4% +$45.4K
MTN icon
81
Vail Resorts
MTN
$5.32B
$1.03M 0.31%
6,864
+516
+8% +$80.1K
VBK icon
82
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
$1.01M 0.31%
3,402
CSGP icon
83
CoStar Group
CSGP
$11.7B
$991K 0.3%
11,751
+308
+3% +$27.2K
VCIT icon
84
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$982K 0.3%
11,678
+686
+6% +$57.1K
BFAM icon
85
Bright Horizons
BFAM
$3.92B
$961K 0.29%
8,847
+349
+4% +$40.4K
WST icon
86
West Pharmaceutical
WST
$24B
$912K 0.28%
3,477
+191
+6% +$46.4K
SYK icon
87
Stryker
SYK
$125B
$906K 0.28%
2,452
+5
+0.2% +$1.93K
VGT icon
88
Vanguard Information Technology ETF
VGT
$139B
$904K 0.28%
9,688
DHR icon
89
Danaher
DHR
$137B
$871K 0.27%
4,395
+74
+2% +$14.7K
MORN icon
90
Morningstar
MORN
$7.22B
$870K 0.27%
3,750
-76
-2% -$20.3K
ADBE icon
91
Adobe
ADBE
$99.5B
$867K 0.26%
2,458
+123
+5% +$44.1K
CP icon
92
Canadian Pacific Kansas City
CP
$78.1B
$858K 0.26%
11,518
-288
-2% -$22K
VHT icon
93
Vanguard Health Care ETF
VHT
$18.1B
$826K 0.25%
3,182
SCZ icon
94
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$799K 0.24%
10,421
-10
-0.1% -$748
PYPL icon
95
PayPal
PYPL
$48.9B
$785K 0.24%
11,712
+413
+4% +$29.1K
VBR icon
96
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$769K 0.23%
3,687
-14
-0.4% -$2.86K
ACN icon
97
Accenture
ACN
$102B
$660K 0.2%
2,678
+57
+2% +$14.9K
VCR icon
98
Vanguard Consumer Discretionary ETF
VCR
$6.15B
$656K 0.2%
1,656
VIGI icon
99
Vanguard International Dividend Appreciation ETF
VIGI
$9.08B
$652K 0.2%
7,275
+142
+2% +$12.7K
IBTF
100
DELISTED
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
$636K 0.19%
27,218
-131,316
-83% -$3.06M

Similar funds

Accretive Wealth Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Accretive Wealth Partners held 156 positions worth $328M, up 7.5% from $305M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Accretive Wealth Partners's Q3 2025 filing shows 6 new, 90 increased, 13 reduced and 4 closed positions. Its largest new stake was iShares iBonds Dec 2035 Term Treasury ETF: 121,970 shares worth $3.11M. The largest sale was iShares iBonds Dec 2025 Term Treasury ETF, an estimated $3.06M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Accretive Wealth Partners's largest Q3 2025 buy was iShares iBonds Dec 2035 Term Treasury ETF: 121,970 shares worth $3.11M.
  • Accretive Wealth Partners added most to iShares Core Dividend Growth ETF in Q3 2025, an estimated $1.66M increase.
  • Accretive Wealth Partners's biggest Q3 2025 reduction was iShares iBonds Dec 2025 Term Treasury ETF, cutting an estimated $3.06M.
  • Accretive Wealth Partners fully exited Equinix in Q3 2025, selling an estimated $1.64M.
  • Accretive Wealth Partners's ten largest holdings make up 37% of its $328M portfolio in Q3 2025.
  • Accretive Wealth Partners opened 6 new positions and closed 4 in Q3 2025.
  • Accretive Wealth Partners's portfolio value rose 7.5% quarter-over-quarter to $328M.

Based on Accretive Wealth Partners's 13F filing for Q3 2025, filed 7 Nov 2025.